CARGO Therapeutics

CARGO Therapeutics is a biotechnology company based in San Mateo, California. The company employs 55 people and generates approximately $50 million in annual revenue. CARGO Therapeutics specializes in developing chimeric antigen receptor (CAR) T-cell therapies for cancer treatment. Their focus is on engineering next-generation CAR T-cell therapies to overcome resistance to existing cancer treatments and address barriers to access, aiming to make these potentially curative therapies available to more patients. The company is dedicated to improving cancer treatment outcomes and patient experiences by pursuing innovative solutions to overcome challenges associated with current CAR T-cell therapies, such as manufacturing complexities, supply limitations, lengthy turnaround times, and reimbursement obstacles. For more information about CARGO Therapeutics and their groundbreaking work in cancer treatment, visit their website at cargo-tx.com.